Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique

Brain Research

Volumn 876, Issue 1-2, 2000, Pages 141-147

  Mahar Doan, Kelly M ^a   Lakhman, Sukhwinder S ^a   Boje, Kathleen M K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aminoguanidine; Blood brain barrier; Cationic amino acids; In situ brain perfusion; Organic cation; Transport

Indexed keywords

AMINOGUANIDINE; ARGININE; CATION; GUANIDINE; GUANIDINE DERIVATIVE; INULIN;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; BRAIN WEIGHT; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFUSION; HYDROPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CARRIER PROTEINS; CATIONS; GUANIDINE; GUANIDINES; INULIN; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

EID: 0343353866     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02643-3     Document Type: Article

References (44)

1. Boje K.M.K., Lakhman S.S. Nitric oxide redox species exert differential permeability effects on the blood-brain barrier. J. Pharmacol. Exp. Ther. 293:2000;545-550.
2. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40:1969;648-677.
3. Christensen H.N., Antonioli J.A. Cationic amino acid transport in the rabbit reticulocyte. J. Biol. Chem. 244:1969;1497-1504.
4. Chun J.K., Zhang L., Piquette-Miller M., Lau E., Tong L.-Q., Giacomini K.M. Characterization of guanidine transport in human renal brush border membranes. Pharm. Res. 14:1997;936-941.
5. Cordon-Cardo C., O’Brien J.P., Casals D., Rittaman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA. 86:1989;695-698.
6. Cornford E.M., Braun L.D., Oldendorf W.H. Carrier-mediated blood-brain barrier transport of choline and certain choline analogs. J. Neurochem. 30:1978;299-308.
7. Deutsch S.I., Oldendorf W.H., Davis K.L. Brain uptake indices of guanidine and 4-aminopyridine. Life Sci. 34:1984;2279-2280.
8. Devés R., Boyd C.A.R. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 78:1998;487-545.
9. +L) in human erythrocytes that recognizes lysine and leucine with high affinity. J. Physiol. (Lond.). 454:1992;491-501.
10. Ganapathy V., Ganapathy M.E., Nair C.N., Mahesh V.B., Leibach F.H. Evidence for an organic cation-proton antiport system in brush-border membranes isolated from the human term placenta. J. Biol. Chem. 263:1988;4561-4568.
11. Grunderman D., Gorboulev V., Gambaryan S., Veyhl M., Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 372:1994;549-552.
12. Hosokawa H., Sawamurai T., Kobayashi S., Ninomiya H., Miwa S., Masaki T. Cloning and characterization of a brain-specific cationic amino acid transporter. J. Biol. Chem. 272:1997;8717-8722.
13. Kakee A., Terasaki T., Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J. Pharmacol. Exp. Ther. 277:1996;1550-1559.
14. + type cationic amino acid transport in Xenopus oocytes and show different tissue expression patterns. Transgene. 1:1993;91-101.
15. Kang Y.S., Terasaki T., Ohnishi T., Tsuji A. In vivo and in vitro evidence for a common carrier-mediated transport of choline and basic drugs through the blood-brain barrier. J. Pharmacobio-Dyn. 13:1990;353-360.
16. Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.-J., Leibach F.H., Ganapathy V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in the placenta. J. Biol. Chem. 273:1998;15971-15979.
17. Lund-Anderson H. Transport of glucose from blood to brain. Physiol. Rev. 59:1979;305-352.
18. MacLeod C.L., Kakuda D.K. Regulation of CAT: cationic amino acid transporter gene expression. Amino Acids. 11:1996;171-191.
19. Mahar Doan K.M., Ng S., Boje K.M.K. Cellular transport processes of aminoguanidine, a nitric oxide synthase inhibitor, in the opossum kidney cell culture line. Int. J. Pharm. 194:2000;209-220.
20. Miyamoto Y., Ganapathy V., Leibach F.H. Transport of guanidine in rabbit intestinal brush-border membrane vesicles. Am. J. Physiol. 255:1988;G85-G92.
21. Miyamoto Y., Tiruppathi C., Ganapathy V., Leibach F.H. Multiple transport systems for organic cations in renal brush-border membranes. Am. J. Physiol. 256:1989;F540-F548.
22. Okuda M., Saito H., Urakami Y., Takano M., Inui K.-I. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224:1996;500-507.
23. Okuda M., Urakami Y., Saito H., Inui K. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes. Biochim. Biophys. Acta. 1417:1999;224-231.
24. Oldendorf W.H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 221:1971;1629-1639.
25. Oldendorf W.H. Blood-brain barrier permeability to lactate. Eur. Neurol. 6:1972;49-55.
26. Oldendorf W.H., Szabo J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230:1976;94-98.
27. Reese T.S., Karnovsky M.J. Fine structural localization of the blood-brain barrier to exogenous peroxidases. J. Cell Biol. 34:1967;207-217.
28. 2+-independent nitric oxide synthases. FEBS J. 291:1991;145-149.
29. Schmidt K., Klatt P., Mayer B. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol. Pharmacol. 44:1993;615-621.
30. Smith Q.R., Momma S., Aoyagi M., Rapoport S.I. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 49:1987;1651-1658.
31. Smith Q.R., Nagura H., Takada Y., Duncan M.W. Facilitated transport of the neurotoxin, β-N-methylamino-L-alanine, across the blood-brain barrier. J. Neurochem. 58:1992;1330-1337.
32. +) of the rat blood-brain barrier. J. Neurochem. 60:1993;1956-1959.
33. Stuhlmiller D.F., Boje K.M.K. Characterization of L-arginine and aminoguanidine uptake into isolated rat choroid plexus: differences in uptake mechanisms and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 65:1995;68-74.
34. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247:1984;H484-H493.
35. Tamai I., Yabuuchi H., Nezu J.I., Sai Y., Oku A., Shimane M., Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:1997;107-111.
36. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M. Cellular localization of the multidrug-resistance gene P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:1987;7735-7738.
37. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37:1989;159-164.
38. +-independent transport of basic and zwitterionic amino acids in mouse blastocysts by a shared system and by processes which distinguish between these substrates. J. Biol. Chem. 263:1988;3150-3163.
39. +-dependent transport of basic, zwitterionic, and bicyclic amino acids by a broad-scope system in mouse blastocysts. J. Biol. Chem. 260:1985;12118-12123.
40. White M.F., Gazzola G.C., Christensen H.N. Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. J. Biol. Chem. 257:1982;4443-4449.
41. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Frederick H.L., Chen J., Conway S.J., Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290:1999;1482-1492.
42. Wu X., Kekuda R., Huang W., Fei Y.J., Leibach F.H., Chen J., Conway S.J., Ganapathy V. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273:1998;32776-32786.
43. Wu X., Prasad P.D., Leibach F.H., Ganapathy V. cDNA sequence, transport, function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246:1998;589-595.
44. Yamashima T., Ohnishi T., Nakajima Y., Teraski T., Tanaka M., Yamashita J., Sasaki T., Tsuji A. Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma. Exp. Brain Res. 95:1993;41-50.